Editor Olivia Friett explores a question facing pharmaceutical manufacturing today: when does complexity stop adding value and start getting in the way?
As we move further into 2025, it's clear the pharmaceutical manufacturing sector is at a pivotal point. We’re seeing real momentum, in the industry - but also a lot of pressure. Olivia Friett, editor of European Pharmaceutical Manufacturer discusses.
Editor, Rebekah Jordan, reviews pharma's transformation to digital solutions, and how the industry will need to navigate the associated risks to prevent breaches in security and safety.
With the ongoing energy crisis, Rebekah Jordan considers the effect of surging manufacturing costs on the pharma sector in Europe, and pharma's hopes to mitigate production and supply chain issues with resiliency and innovation.
In this editor's desk, Rebekah Jordan shares her views on the achievements within pharma sustainability in 2022, its criticality in pharma investment opportunities, and what's still to be done.
Rebekah Jordan shares her view from the seat at the Editor’s Desk on what impact the post-Brexit era might have on the UK process of medicine approvals and how external pharma manufacturers may respond.
Robert Harrison, pharmaceutical industry manager of COPA-DATA, explains how appropriate technologies can help, rather than hinder, essential regulatory compliance.
